Fate Therapeutics Inc (FATE) — SC 13D/A Filings
All SC 13D/A filings from Fate Therapeutics Inc. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Redmile Group Adjusts Fate Therapeutics Stake
— Mar 25, 2024 Risk: medium
Redmile Group, LLC, through its affiliate Redco II Master Fund, L.P., has amended its Schedule 13D filing regarding Fate Therapeutics, Inc. as of March 25, 2024
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX